论文部分内容阅读
一项多国合作、随机、双盲、平行对照研究,比较了两种HMG-CoA还原酶抑制剂拜斯亭和普伐他汀治疗原发性高胆固醇血症患者的长期效果和安全性。
A multinational, randomized, double-blind, parallel-controlled study comparing the long-term efficacy and safety of two HMG-CoA reductase inhibitors, Besite and pravastatin in patients with primary hypercholesterolemia.